A significant advance in cancer investigation is arising with the use of mini-antibodies to re-engage dysfunctional p53. This vital tumor suppressor protein is frequently disabled in several types of malignancies, https://ezmarkbookmarks.com/story22077097/mini-antibodies-revive-the-p53-protein-the-potential-approach-for-tumor-management